(Press-News.org) RICHMOND, Va. (Jan. 4, 2011) – Virginia Commonwealth University School of Medicine researchers have found that a significant increase of an enzyme in the blood vessels of pregnant women with preeclampsia may explain some of the symptoms associated with the condition, including hypertension, swelling and protein in the urine.
The findings could lead to a treatment for pregnant women with preeclampsia, which is one of the most significant health problems in pregnancy and a leading cause worldwide of both premature delivery and of sickness and death of the mother and baby.
Preeclampsia, a condition which occurs in one out of 20 pregnancies, is diagnosed when the mother develops high blood pressure and starts losing protein in her urine after 20 weeks of pregnancy. Research has shown that the blood vessels of women with preeclampsia are dysfunctional, but the cause of preeclampsia is not known, and the only treatment is delivery of the baby.
In a study published in the January issue of The American Journal of Pathology, the VCU team reported a significant increase in an enzyme called MMP-1 in blood vessels of women with preeclampsia and an imbalance in collagen-regulating genes that favored the breakdown of collagen. MMP-1 is an enzyme produced in tissues under conditions of inflammation that acts to break down collagen.
"The increase in MMP-1 that we found would compromise the integrity of the mother's blood vessels, which could explain two of the clinical symptoms of preeclampsia – edema and proteinuria," said corresponding author Scott Walsh, Ph.D., professor in the VCU Department of Obstetrics and Gynecology.
The swelling experienced by pregnant women with preeclampsia is due to edema, which is a leakage of protein out of the blood vessels into surrounding tissues. Proteinuria is a leakage of protein through the blood vessels of the kidney and into the urine.
The team also found that MMP-1 causes blood vessel contraction by activation of a receptor known as PAR1, which according to Walsh, could explain the hypertension, or high blood pressure, of women with preeclampsia.
"This finding may be especially important for preeclampsia because we found increased amounts of PAR1 in blood vessels of preeclamptic women as compared to normal pregnant women. MMP-1 activation of PAR1 is a totally new mechanism to explain hypertension," Walsh said.
PAR1 is best known for its role in the coagulation of blood, but it is not known for a role in hypertension, said Walsh.
Further, the team showed that neutrophils, or white blood cells, and neutrophil products increase MMP-1 and PAR1. According to Walsh, neutrophil infiltration may be the cause of the increase in MMP-1 and PAR1 in blood vessels that leads to vessel dysfunction and clinical symptoms of preeclampsia.
"Activation of the PAR1 receptor by MMP-1 causes changes in the endothelial cells of blood vessels that we speculated could result in contraction of blood vessels. This new information provides a rationale for the use of PAR1 inhibitors to treat preeclampsia," said Walsh.
###
This work was supported by grants from the National Heart, Lung and Blood Institute, the National Center on Minority Health and Health Disparities, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and Fogarty International.
Walsh collaborated with said Jerome F. Strauss, III, M.D., Ph.D., dean of the VCU School of Medicine; Guadalupe Estrada-Guitierrez, Ph.D., Fogarty Scholar with the VCU Department of Obstetrics and Gynecology, and the Instituto Nacional de Perinatologia in Mexico City, Mexico; Renato Cappello, Ph.D., with the VCU Department of Obstetrics and Gynecology; Nikita Mishra Ph.D., with the VCU Department of Obstetrics and Gynecology and Physiology and Biophysics; Roberto Romero, Ph.D., Chief Perinatology Research Branch, NICHD/NIH, and Department of Obstetrics and Gynecology, Wayne State University/Hutzel Hospital, Detroit.
EDITOR'S NOTE: A copy of the article is available to reporters by email request from Audra E. Cox, Ph.D., managing editor of The American Journal of Pathology at acox@asip.org.
About VCU and the VCU Medical Center: Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located on two downtown campuses in Richmond, VCU enrolls more than 32,000 students in 211 certificate and degree programs in the arts, sciences and humanities. Sixty-nine of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see www.vcu.edu.
News Directors: Broadcast access to VCU experts can be arranged through the university's VideoLink ReadyCam studio. ReadyCam transmits video and audio via fiber optics through a system that is routed to your newsroom. To schedule a live or taped interview, contact the VCU Office of Communications and Public Relations, (804) 828-1231.
END
All of us may be able to breathe a little easier now that scientists from Pennsylvania have found a new therapeutic target for controlling dangerous inflammation in the lungs. A new research report in the January 2011 issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) suggests that blocking the activation of an enzyme called delta-protein kinase C (delta-PKC) could protect the lungs from neutrophil-mediated damage, which can result in out of control inflammation. In an animal model of acute respiratory distress syndrome (ARDS), inhibiting delta-PKC in ...
For decades, doctors have looked at fitness levels, weight, and overall health risk factors for heart disease and stroke. Now, they may soon add a new risk factor to the list: activation of the complement system. The complement system is usually implicated in immune responses, but now there's a role for it in cardiovascular disease. In a new research report appearing in the January 2011 print issue of the FASEB Journal (http://www.fasebj.org), scientists from Europe and the United States show that anaphylatoxin C5a, a protein released when complement is activated, contributes ...
Kris Wheaton pushes a key on his computer and the reminder transmits to dozens of intelligence studies students: Game Lab Tonight!
Himself a long-time gamer, Wheaton is a pioneer in game-based learning as it applies to the teaching of intelligence analysis.
Whether wrangling over the next move in "Defiant Russia," a board game based on the 1941 German attack on the Soviet Union, where players control the units that fought in the campaign; or strategizing over the online musical puzzle journey that is "Auditorium," there's lots of learning going on.
"In terms of ...
PROVIDENCE, RI – Just as the site for the 2013 America's Cup has been announced, a study from Rhode Island Hospital highlights that the sport isn't always smooth sailing. The study was published recently in the journal Wilderness and Environmental Medicine.
Through an on-line survey completed by sailors, researchers at Rhode Island Hospital have pieced together a report of the injuries that occur on two types of boats -- dinghies (small boats with crews of one or two) and keel boats (larger boats like those used in the America's Cup races with a crew of up to 16).
With ...
WESTERVILLE, OH – Nearly one year after a 7.0-magnitude earthquake rocked the Republic of Haiti, engineering and concrete experts at Georgia Tech report that concrete and other debris in Port-au-Prince could be safely and inexpensively recycled into strong new construction material.
In a paper published today in the Bulletin of the American Ceramic Society, researchers Reginald DesRoches, Kimberly E. Kurtis and Joshua J. Gresham say that they have made new concrete, which meets or exceeds the minimum strength standards used in the United States, from recycled concrete ...
Boston, Mass. – When pregnant women need medications, there is often concern about possible effects on the fetus. Although some drugs are clearly recognized to cause birth defects (thalidomide being a notorious example), and others are generally recognized as safe, surprisingly little is known about most drugs' level of risk. Researchers in the Children's Hospital Boston Informatics Program (CHIP) have created a preclinical model for predicting a drug's teratogenicity (tendency to cause fetal malformations) based on characterizing the genes that it targets.
The model, ...
CORVALLIS, Ore. – There is a lot of plastic trash floating in the Pacific Ocean, but claims that the "Great Garbage Patch" between California and Japan is twice the size of Texas are grossly exaggerated, according to an analysis by an Oregon State University scientist.
Further claims that the oceans are filled with more plastic than plankton, and that the patch has been growing tenfold each decade since the 1950s are equally misleading, pointed out Angelicque "Angel" White, an assistant professor of oceanography at Oregon State.
"There is no doubt that the amount of ...
AURORA, Colo. (Jan. 4, 2011) - Researchers at the University of Colorado School of Medicine have created a new and exciting mouse model to study how lipid sensing and metabolism in the brain relate to the regulation of energy balance and body weight. The research team, led by Hong Wang, PhD, created mice with a deficiency of lipoprotein lipase (LPL) in neurons, and observed two important reactions. First, the mouse models ate more and second, they became sedentary. Because LPL is important to the delivery of fatty acids to the brain, these responses spotlight the importance ...
LA JOLLA, CA – January 4, 2011 — Researchers from The Scripps Research Institute, Weill Cornell Medical College, and Cornell University have produced a long-lasting anti-cocaine immunity in mice by giving them a unique vaccine that combines bits of the common cold virus with a particle that mimics cocaine.
In their study, published January 4, 2011, in the advanced online edition of Molecular Therapy, the researchers say this novel strategy might be the first to offer cocaine addicts a fairly simple way to break and reverse their habit. The approach could also be useful ...
DURHAM, N.C. – A tiny light source and sensors at the end of an endoscope may provide a more accurate way to identify pre-cancerous cells in the lining of the esophagus.
Developed by biomedical engineers at Duke University and successfully tested on patients during a clinical trial at the University of North Carolina at Chapel Hill, the device holds the promise of being a less invasive method for testing patients suspected of having Barrett's esophagus, a change in the lining of the esophagus due to acid reflux. Acid reflux occurs when stomach acid splashes, or refluxes, ...
